More Evidence Supporting the Ban of Ephedra Dietary Supplements

1. Robinson RF , Griffith JR , Nahata MC , Mahan JD , Casavant MJ . Herbal weight-loss supplement misadventures per a regional poison center. Ann Pharmacother 2004; 787–90. DOI 10.1345/aph.1D260

2. Blanck HM , Khan LK , Serdula MK . Use of nonprescription weight loss products: results of a multistate survey. JAMA 2001; 286: 930–5.

3. Watson WA , Litovitz TL , Rodgers GC Jr , Klein-Schwartz W , Youniss J , Rose SR , 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003; 21: 353–421.

4. Blumenthal M , ed. The ABC clinical guide to herbs. Austin, TX: American Botanical Council, 2003: 107–21.

5. Shekelle P , Morton S , Maglione M , Roth E , Jungvig L . Mojica WA , Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects. Evidence Report/Technology Assessment no. 76 (Prepared by Southern California Evidence-based Practice Center, RAND under Contract no. 290-97-0001, Task Order no. 9.) AHRQ Publication no. 03-E022. Rockville, MD: Agency for Healthcare Research and Quality, February 2003.

6. US Food and Drug Administration. Dietary Supplement Health and Education Act of 1994. http://vm.cfsan.fda.gov/∼dms/dietsupp.html (accessed 2004 Jan 10).

7. Office of Inspector General, Department of Health and Human Services. Adverse event reports of dietary supplements: an inadequate safety valve. April 2001. http://oig.hhs.gov/oei/reports/oei-01-00-00180.pdf (accessed 2004 Jan 10).

8. Ephedra: heart dangers in disguise. Consum Rep 2004; 69 (1): 22–3.

9. Bell C . The Testimony of Mr. Charles Bell. Programs Director, Consumers Union. Given to Full US Senate Committee Hearing: Dietary Supplements. October 28 2003. www.senate.gov?∼commerce/hearings/testimony.cfm?id=976&wit_id=2750 (accessed 2004 Jan 10).

10. US Department of Health and Human Services, US Food & Drug Administration, Center for Food Safety and Applied. Nutrition dietary supplements: ephedrine alkaloids. www.cfsan.fda.gov/∼dms/ds-ephed.html (accessed 2004 Mar 12).

11. Shekelle PG , Hardy ML , Morton SC , Maglione M , Mojica WA , Suttorp MJ , Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003; 289: 1537–45.

12. Taylor H , Leitman R , eds. Widespread ignorance of regulation and labeling of vitamins, minerals and food supplements, according to a National Harris Interactive Survey. Harris Interactive Health Care News 2002; 2 (23): 1–5. www.harrisinteractive.com/news/newsletters_healthcare.asp) (accessed 2004 Jan 10).

13. Fontanarosa PB , Rennie D , DeAngelis CD . The need for regulation of dietary supplements: lessons from ephedra (editorial). JAMA 2003; 289: 1568–70.

14. Guharoy R , Noviasky JA . Time to ban ephedra—now. Am J Health Syst Pharm 2003; 60: 1580–2.

15. Dietary Supplement Safety Act of 2003. 108th Congress, 1st Session. March 26, 2003. www.theorator.com/bills108/s722.html (accessed 2004 Jan 20).

16. Dietary Supplement Access and Awareness Act. 108th Congress, 1st Session. October 28, 2003. www.apha.org/HR3377_Davis_DSAAA.pdf (accessed 2004 Jan 20).